T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.72% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Equinor
EQNR
$96.3B
| $7.34M | ﹤0.01% |
205,100
+6,008
| +3% | +$216K |
|
1102
Ollie's Bargain Outlet
OLLI
$4.73B
| $7.31M | ﹤0.01% |
156,128
-2,325
| -1% | -$125K |
|
1103
Patrick Industries
PATK
$2.79B
| $7.29M | ﹤0.01% |
180,471
-116,942
| -39% | -$4.07M |
|
1104
Remitly
RELY
$5.39B
| $7.27M | ﹤0.01% |
634,823
-157,219
| -20% | -$1.63M |
|
|
ARNC
1105
DELISTED
Arconic Corporation
ARNC
| $7.25M | ﹤0.01% |
342,556
-96,017
| -22% | -$2.01M |
|
1106
Cloudflare
NET
$118B
| $7.24M | ﹤0.01% |
160,223
-544
| -0.3% | -$26.9K |
|
|
PYCR
1107
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $7.16M | ﹤0.01% |
292,382
+58,654
| +25% | +$1.62M |
|
1108
Carriage Services
CSV
$535M
| $7.01M | ﹤0.01% |
254,517
+2,765
| +1% | +$75.2K |
|
1109
Marqeta
MQ
$1.71B
| $6.97M | ﹤0.01% |
285,343
-156
| -0.1% | -$4.26K |
|
1110
StepStone Group
STEP
$3.96B
| $6.94M | ﹤0.01% |
275,507
+7,459
| +3% | +$209K |
|
1111
Philips
PHG
$26.8B
| $6.92M | ﹤0.01% |
539,502
+8,812
| +2% | +$106K |
|
1112
NorthWestern Energy
NWE
$4.4B
| $6.92M | ﹤0.01% |
116,599
+21,661
| +23% | +$1.18M |
|
1113
RB Global
RBA
$16B
| $6.86M | ﹤0.01% |
118,655
| – | – |
|
1114
Ginkgo Bioworks
DNA
$488M
| $6.86M | ﹤0.01% |
101,471
-3,927
| -4% | -$361K |
|
1115
Orchestra BioMed
OBIO
$266M
| $6.85M | ﹤0.01% |
685,801
-38,764
| -5% | -$386K |
|
1116
nCino
NCNO
$2.26B
| $6.83M | ﹤0.01% |
258,371
-3,717,437
| -94% | -$105M |
|
1117
Hanover Insurance
THG
$7.74B
| $6.76M | ﹤0.01% |
50,002
-5,557
| -10% | -$775K |
|
1118
Morningstar
MORN
$7.41B
| $6.74M | ﹤0.01% |
31,123
+662
| +2% | +$151K |
|
1119
Norwegian Cruise Line
NCLH
$8.98B
| $6.73M | ﹤0.01% |
549,905
+5,686
| +1% | +$85.6K |
|
|
PCH
1120
DELISTED
PotlatchDeltic
PCH
| $6.62M | ﹤0.01% |
150,516
+11,049
| +8% | +$500K |
|
1121
DaVita
DVA
$11.6B
| $6.56M | ﹤0.01% |
87,903
+6,665
| +8% | +$518K |
|
1122
Okta
OKTA
$26.9B
| $6.55M | ﹤0.01% |
95,940
-3,847
| -4% | -$220K |
|
1123
Ardelyx
ARDX
$1.01B
| $6.54M | ﹤0.01% |
+2,296,426
| New | +$3.89M |
|
|
THRX
1124
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $6.54M | ﹤0.01% |
1,313,908
-67,581
| -5% | -$396K |
|
1125
Vale
VALE
$58.7B
| $6.54M | ﹤0.01% |
+385,340
| New | +$5.79M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.